Feature | April 10, 2014

Ten-Year-Old Boy is Florida’s First Pediatric Patient to Receive S-ICD

April 10, 2014 — Cardiologists at Arnold Palmer Hospital for Children performed Florida’s first pediatric implant of a new device to prevent sudden cardiac arrest.

The device, called a subcutaneous defibrillator, protects patients from sudden cardiac arrest by providing an electrical impulse to muscles surrounding the heart. It is the world’s first device to provide protection from sudden cardiac arrest while not touching the heart or blood vessels.

Sudden cardiac arrest is a condition in which the heart suddenly and unexpectedly stops beating. If this happens, blood stops flowing to the brain and other vital organs. The condition usually causes death if not treated within minutes. [1]

Cardiologists at the hospital implanted the subcutaneous defibrillator into Jose Ramos, a 10-year-old Kissimmee, Fla., boy who went into sudden cardiac arrest in February 2014 and received cardiopulmonary resuscitation from his father to save his life.

“With the subcutaneous defibrillator, we now have a way to prevent sudden cardiac arrest in pediatric patients without having wires running through their veins and into the heart,” says Rodrigo Nehgme, electrophysiologist and cardiologist at Arnold Palmer Hospital. “It is a less invasive solution with fewer risks and will save the lives of young patients at risk for sudden cardiac arrest.”

The subcutaneous defibrillator is about the size of a deck of cards and is implanted just beneath the skin below the armpit. Cardiologists then run a wire, also beneath the skin, from the device to the front of the chest and up toward the neck. Whereas older technology monitored individual heartbeats, this new device actually analyzes heart rhythm and provides an electrical impulse when the heart goes into a dangerous rhythm.

Approximately 2,000 of the subcutaneous defibrillators have been implanted in the United States, with Ramos being only the fifth pediatric case.

References:

1. National Heart, Lung and Blood Institute (https://www.nhlbi.nih.gov/health/health-topics/topics/scda/)

For more information: www.arnoldpalmerhospital.com

 

Related Content

Boston Scientific Launches Resonate Devices With HeartLogic Heart Failure Diagnostic
Technology | Implantable Cardioverter Defibrillator (ICD) | September 27, 2017
September 27, 2017 — Boston Scientific recently launched the Resonate family of...
Abbott Secures FDA Approval for MRI Compatibility on Ellipse ICD
Technology | Implantable Cardioverter Defibrillator (ICD) | September 22, 2017
Abbott announced U.S. Food and Drug Administration (FDA) approval for magnetic resonance (MR)-conditional labeling for...
Predictive Models May Help Determine Which Patients Benefit From ICDs
News | Implantable Cardioverter Defibrillator (ICD) | July 06, 2017
Two predictive models may help cardiologists decide which patients would most benefit from an implantable cardioverter...
Videos | Implantable Cardioverter Defibrillator (ICD) | June 01, 2017
Lucas Boersma, M.D., Ph.D., FESC, St.
The Unify ICD is one of the SJM devices in an FDA warning letter
Feature | Implantable Cardioverter Defibrillator (ICD) | April 14, 2017 | Dave Fornell
April 14, 2017 — The U.S. Food and Drug Administration (FDA) sent a warning letter to Abbott/St.
ICDs, non-ischemic cardiomyopathy, University of Alabama at Birmingham study, Circulation
News | Implantable Cardioverter Defibrillator (ICD) | January 18, 2017
A new study published in Circulation has found there is a 23 percent risk in reduction of all-cause mortality in non-...
ICDs, implantable cardioverter defibrillators, survival rate, elderly patients, JACC study
News | Implantable Cardioverter Defibrillator (ICD) | January 17, 2017
Of patients over age 65 who received an implantable cardioverter-defibrillator (ICD) after surviving sudden cardiac...
Overlay Init